Form 4: Vor Biopharma Insider Sells Shares
Insider Transaction (Form 4)
Ra Capital Management, L.P. and 3 others reported changes in beneficial ownership of Vor Biopharma Inc. common stock on July 16, 2026.
Summary
- In-the-money derivative exercise: acquired 2,100,000 Common Stock at $0.00 ($4,200) on July 16, 2026; holds 4,502,095 after (Indirect).
- Open-market sale: disposed of 213 Common Stock at $19.75 ($4,207) on July 16, 2026; holds 4,501,882 after (Indirect).
- In-the-money derivative exercise: disposed of 2,100,000 Pre-Funded Warrant (Right to Buy) at $5.00 ($10,500,000) on July 16, 2026; holds 7,900,000 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $4,207 of stock on the open market.
Insider Transactions
Ra Capital Management, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Peter Kolchinsky — 10% owner
Rajeev M. Shah — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | In-the-money derivative exercise | Common Stock | 2,100,000 | $0 | $4.2K | 4,502,095 |
| 2026-07-16 | Open-market sale | Common Stock | 213 | $20 | $4.2K | 4,501,882 |
| 2026-07-16 | In-the-money derivative exercise | Pre-Funded Warrant (Right to Buy) | 2,100,000 | $5 | $10.5M | 7,900,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | In-the-money derivative exercise (2,100,000 shares) |
| 2026-07-16 | Open-market sale (213 shares) |
| 2026-07-16 | In-the-money derivative exercise (2,100,000 shares) |
Keywords
insider transaction, Form 4, VOR, Vor Biopharma Inc., bearish, Ra Capital Management, L.P., RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev M. Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.